Cargando...
Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors
Checkpoint inhibitor (CPI) blockade is considered to be a revolution in cancer therapy, although most patients (70%–80%) remain resistant to this therapy. It has been hypothesized that only tumors with high mutation rates generate a natural antitumor T cell response, which could be revigorated by th...
Gardado en:
| Publicado en: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5192357/ https://ncbi.nlm.nih.gov/pubmed/27827885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines4040037 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|